Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
H
Hatzokos, I., Gigis I., Iosifidou E., Drakou A., & Pournaras J. (2005).  Primary haemangiopericytoma of the tibia. Treatment by en bloc resection and bone transportation. A case report.. Acta Orthop Belg. 71(1), 122-7.
Hatzitolios, A. I., Athyros V. G., Karagiannis A., Savopoulos C., Charalambous C., Kyriakidis G., et al. (2009).  Implementation of strategy for the management of overt dyslipidemia: the IMPROVE-dyslipidemia study.. Int J Cardiol. 134(3), 322-9.
Hatzitolios, A., Ntaios G., & Savopoulos C. (2009).  Amiodarone: pharmacological profile, animal-model experimental data and clinical use. How important is the vasodilating effect?. Int Angiol. 28(5), 353-62.
Hatzitolios, A. I., Didangelos T. P., Zantidis A. T., Tziomalos K., Giannakoulas G. A., & Karamitsos D. T. (2009).  Diabetes mellitus and cerebrovascular disease: which are the actual data?. J Diabetes Complications. 23(4), 283-96.
Hatzitolios, A. I., Spanou M., Dambali R., Vraka K., Doumarapis E., Petratos K., et al. (2014).  Public awareness of stroke symptoms and risk factors and response to acute stroke in Northern Greece.. Int J Stroke. 9(4), E15.
Hatzistilianou, M., Rekliti A., Athanassiadou F., & Catriu D. (2010).  Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia.. Inflamm Res. 59(5), 339-47.
Hatzistilianou, M. (2010).  Diagnostic and prognostic role of procalcitonin in infections.. ScientificWorldJournal. 10, 1941-6.
Hatzistavri, L. S., Sarafidis P. A., Georgianos P. I., Tziolas I. M., Aroditis C. P., Zebekakis P. E., et al. (2009).  Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension.. Am J Hypertens. 22(10), 1070-5.
Hatzipantelis, E., Pana Z. D., Pavlou E., Balakou E., Tsotoulidou V., Papageorgiou T., et al. (2011).  Epileptic seizures after octreotide administration in a 6.5-year-old female with ALL and L-asparaginase associated pancreatitis: a possible drug interaction.. Klin Padiatr. 223(6), 360-3.
Hatzipantelis, E., Panagopoulou P., Sidi-Fragandrea V., Fragandrea I., & Koliouskas D. E. (2010).  Carcinoid tumors of the appendix in children: experience from a tertiary center in northern Greece.. J Pediatr Gastroenterol Nutr. 51(5), 622-5.
Hatzipantelis, E., Pana Z. Dorothea, Papageorgiou T., Hatzistilianou M., Athanasiadou A., Sarafidis K., et al. (2014).  Congenital acute lymphoblastic leukemia case with a novel t(2:4:11) (p21:q21:q23) translocation.. Pediatr Hematol Oncol. 31(2), 178-80.
Hatzipantelis, E., Kyriakidis I., Pavlou E., & Pavlidou E. (2015).  Bilateral Eyelid Ptosis, Attributed to Vincristine, Treated Successfully with Pyridoxine and Thiamine in a Child with Acute Lymphoblastic Leukemia.. Toxicol Int. 22(1), 162-4.
Hatzipantelis, E., Pana Z., Tsotoulidou V., Kalogera A., Diakou A., Pantoleon A., et al. (2017).  Visceral larva migrans due to Toxocara canis in a 9-year-old boy mimicking hepatic hemangiomas.. J Paediatr Child Health. 53(5), 517-519.
Hatzipantelis, E. S., Pana Z. Dorothea, Gombakis N., Taparkou A., Tzimouli V., Kleta D., et al. (2013).  Endothelial activation and inflammation biomarkers in children and adolescents with sickle cell disease.. Int J Hematol. 98(2), 158-63.
Hatzipantelis, E. S., Karasmanis K., Perifanis V., Vlachaki E., Tziomalos K., & Economou M. (2014).  Combined chelation therapy with deferoxamine and deferiprone in β-thalassemia major: compliance and opinions of young thalassemic patients.. Hemoglobin. 38(2), 111-4.
Hatzipantelis, E., Pana Z. Dorothea, Vlachou M., Papageorgiou T., Tragiannidis A., & Athanassiadou F. (2014).  Peripheral blood lymphocyte recovery and overall survival in pediatric acute lymphoblastic leukemia.. Pediatr Blood Cancer. 61(1), 181-3.
Hatzipantelis, E. S., Athanassiou-Metaxa M., Gombakis N., Tzimouli V., Taparkou A., Sidi-Fragandrea V., et al. (2011).  Thrombomodulin and von Willebrand factor: relation to endothelial dysfunction and disease outcome in children with acute lymphoblastic leukemia.. Acta Haematol. 125(3), 130-5.
Hatzipantelis, E., Kyriakidis I., Pavlou E., Pavlidou E., Stamou M., Foroglou N., et al. (2015).  Lumbar puncture complicated by spinal epidural hematoma in a child with leukemia.. Clin Case Rep. 3(6), 388-91.
Hatzipantelis, E. S., & Dinas K. (2010).  Ovarian tumours in childhood and adolescence.. Eur J Gynaecol Oncol. 31(6), 616-20.
Hatzimouratidis, K., & Hatzichristou D. (2014).  How to treat erectile dysfunction in men with diabetes: from pathophysiology to treatment.. Curr Diab Rep. 14(11), 545.
Hatzimouratidis, K. (2010).  Re: Penile sonographic and clinical characteristics in men with Peyronie's disease.. Eur Urol. 57(5), 918.
Hatzimouratidis, K., Amar E., Eardley I., Giuliano F., Hatzichristou D., Montorsi F., et al. (2010).  Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation.. Eur Urol. 57(5), 804-14.
Hatzimouratidis, K. (2009).  Phosphodiesterase type 5 inhibitors: a viable treatment option for lower urinary tract symptoms?. Expert Opin Investig Drugs. 18(3), 245-54.
Hatzimouratidis, K., Eardley I., Giuliano F., Hatzichristou D., Moncada I., Salonia A., et al. (2012).  EAU guidelines on penile curvature.. Eur Urol. 62(3), 543-52.
Hatzimouratidis, K., & Hatzichristou D. G. (2009).  Phosphodiesterase type 5 inhibitors: unmet needs.. Curr Pharm Des. 15(30), 3476-85.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές